1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Tate, S.
Tate, N.U.
Ushioda, T.
Samejima, T.
Kainosho, M.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
34
14637
14648
10.1021/bi00045a004
7578072
Solution structure of a human cystatin A variant, cystatin A2-98 M65L, by NMR spectroscopy. A possible role of the interactions between the N- and C-termini to maintain the inhibitory active form of cystatin A.
1995
10.2210/pdb1cyv/pdb
pdb_00001cyv
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
11002.426
CYSTATIN A
DEL(M1), M65L
1
man
polymer
STEFIN A
no
no
MIPGGLSEAKPATPEIQEIVDKVKPQLEEKTNETYGKLEAVQYKTQVVAGTNYYIKVRAGDNKYLHLKVFKSLPGQNEDL
VLTGYQVDKNKDDELTGF
MIPGGLSEAKPATPEIQEIVDKVKPQLEEKTNETYGKLEAVQYKTQVVAGTNYYIKVRAGDNKYLHLKVFKSLPGQNEDL
VLTGYQVDKNKDDELTGF
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
9606
Homo sapiens
562
Escherichia coli
database_2
pdbx_database_related
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1995-12-07
1
1
2008-03-24
1
2
2011-07-13
1
3
2021-11-03
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_related.content_type
_pdbx_database_related.details
_pdbx_database_status.process_site
_struct_ref_seq_dif.details
ensemble
Y
BNL
1995-08-24
REL
1
BRUNGER
refinement
X-PLOR
3.1
MET
1
n
1
MET
1
A
ILE
2
n
2
ILE
2
A
PRO
3
n
3
PRO
3
A
GLY
4
n
4
GLY
4
A
GLY
5
n
5
GLY
5
A
LEU
6
n
6
LEU
6
A
SER
7
n
7
SER
7
A
GLU
8
n
8
GLU
8
A
ALA
9
n
9
ALA
9
A
LYS
10
n
10
LYS
10
A
PRO
11
n
11
PRO
11
A
ALA
12
n
12
ALA
12
A
THR
13
n
13
THR
13
A
PRO
14
n
14
PRO
14
A
GLU
15
n
15
GLU
15
A
ILE
16
n
16
ILE
16
A
GLN
17
n
17
GLN
17
A
GLU
18
n
18
GLU
18
A
ILE
19
n
19
ILE
19
A
VAL
20
n
20
VAL
20
A
ASP
21
n
21
ASP
21
A
LYS
22
n
22
LYS
22
A
VAL
23
n
23
VAL
23
A
LYS
24
n
24
LYS
24
A
PRO
25
n
25
PRO
25
A
GLN
26
n
26
GLN
26
A
LEU
27
n
27
LEU
27
A
GLU
28
n
28
GLU
28
A
GLU
29
n
29
GLU
29
A
LYS
30
n
30
LYS
30
A
THR
31
n
31
THR
31
A
ASN
32
n
32
ASN
32
A
GLU
33
n
33
GLU
33
A
THR
34
n
34
THR
34
A
TYR
35
n
35
TYR
35
A
GLY
36
n
36
GLY
36
A
LYS
37
n
37
LYS
37
A
LEU
38
n
38
LEU
38
A
GLU
39
n
39
GLU
39
A
ALA
40
n
40
ALA
40
A
VAL
41
n
41
VAL
41
A
GLN
42
n
42
GLN
42
A
TYR
43
n
43
TYR
43
A
LYS
44
n
44
LYS
44
A
THR
45
n
45
THR
45
A
GLN
46
n
46
GLN
46
A
VAL
47
n
47
VAL
47
A
VAL
48
n
48
VAL
48
A
ALA
49
n
49
ALA
49
A
GLY
50
n
50
GLY
50
A
THR
51
n
51
THR
51
A
ASN
52
n
52
ASN
52
A
TYR
53
n
53
TYR
53
A
TYR
54
n
54
TYR
54
A
ILE
55
n
55
ILE
55
A
LYS
56
n
56
LYS
56
A
VAL
57
n
57
VAL
57
A
ARG
58
n
58
ARG
58
A
ALA
59
n
59
ALA
59
A
GLY
60
n
60
GLY
60
A
ASP
61
n
61
ASP
61
A
ASN
62
n
62
ASN
62
A
LYS
63
n
63
LYS
63
A
TYR
64
n
64
TYR
64
A
LEU
65
n
65
LEU
65
A
HIS
66
n
66
HIS
66
A
LEU
67
n
67
LEU
67
A
LYS
68
n
68
LYS
68
A
VAL
69
n
69
VAL
69
A
PHE
70
n
70
PHE
70
A
LYS
71
n
71
LYS
71
A
SER
72
n
72
SER
72
A
LEU
73
n
73
LEU
73
A
PRO
74
n
74
PRO
74
A
GLY
75
n
75
GLY
75
A
GLN
76
n
76
GLN
76
A
ASN
77
n
77
ASN
77
A
GLU
78
n
78
GLU
78
A
ASP
79
n
79
ASP
79
A
LEU
80
n
80
LEU
80
A
VAL
81
n
81
VAL
81
A
LEU
82
n
82
LEU
82
A
THR
83
n
83
THR
83
A
GLY
84
n
84
GLY
84
A
TYR
85
n
85
TYR
85
A
GLN
86
n
86
GLN
86
A
VAL
87
n
87
VAL
87
A
ASP
88
n
88
ASP
88
A
LYS
89
n
89
LYS
89
A
ASN
90
n
90
ASN
90
A
LYS
91
n
91
LYS
91
A
ASP
92
n
92
ASP
92
A
ASP
93
n
93
ASP
93
A
GLU
94
n
94
GLU
94
A
LEU
95
n
95
LEU
95
A
THR
96
n
96
THR
96
A
GLY
97
n
97
GLY
97
A
PHE
98
n
98
PHE
98
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
LYS
10
A
O
LYS
10
A
N
TYR
43
A
N
TYR
43
A
N
GLN
46
A
N
GLN
46
A
O
ASN
52
A
O
ASN
52
A
O
VAL
57
A
O
VAL
57
A
N
LEU
65
A
N
LEU
65
A
N
GLU
39
A
N
GLU
39
A
O
ARG
58
A
O
ARG
58
A
O
VAL
57
A
O
VAL
57
A
N
LEU
65
A
N
LEU
65
A
N
LYS
68
A
N
LYS
68
A
O
GLY
84
A
O
GLY
84
1
A
ARG
58
0.240
SIDE CHAIN
1
A
PRO
3
-77.53
-169.17
1
A
LEU
6
-55.90
-165.43
1
A
SER
7
61.29
-88.57
1
A
ALA
9
-172.29
149.58
1
A
ALA
12
32.66
100.17
1
A
LYS
22
-108.17
-73.41
1
A
GLU
29
-144.30
20.52
1
A
LYS
30
-92.93
-65.75
1
A
ASN
32
35.42
42.00
1
A
THR
34
-90.51
38.78
1
A
TYR
35
-140.51
-152.57
1
A
LEU
38
-114.95
60.89
1
A
GLU
39
179.05
-151.20
1
A
GLN
42
168.84
166.56
1
A
VAL
47
-63.25
-158.54
1
A
VAL
48
164.85
-50.84
1
A
ALA
49
159.50
47.55
1
A
THR
51
108.96
93.83
1
A
LEU
73
-179.16
60.52
1
A
PRO
74
-81.02
49.64
1
A
ASN
77
56.73
93.23
1
A
ASP
79
45.73
-166.66
1
A
LEU
80
-100.34
-147.07
1
A
VAL
81
179.20
160.57
1
A
THR
83
-55.15
-8.86
1
A
TYR
85
165.71
121.91
1
A
VAL
87
-90.01
-144.95
1
A
ASP
88
-130.19
-144.34
1
A
LYS
89
81.88
55.54
1
A
ASN
90
39.90
37.58
1
A
LYS
91
-105.45
-61.24
1
A
GLU
94
-179.10
135.39
1
A
LEU
95
-48.27
163.86
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
phasing
X-PLOR
3.1
SOLUTION NMR STRUCTURE OF RECOMBINANT HUMAN CYSTATIN A UNDER THE CONDITION OF PH 3.8 AND 310K
1
Y
N
A
GLU
15
A
GLU
15
HELX_P
A
LYS
22
A
LYS
22
1
H1
8
A
GLN
26
A
GLN
26
HELX_P
A
LYS
30
A
LYS
30
1
H2
5
PROTEINASE INHIBITOR (CYSTEINE)
PROTEINASE INHIBITOR (CYSTEINE)
CYTA_HUMAN
UNP
1
1
P01040
MIPGGLSEAKPATPEIQEIVDKVKPQLEEKTNETYGKLEAVQYKTQVVAGTNYYIKVRAGDNKYMHLKVFKSLPGQNEDL
VLTGYQVDKNKDDELTGF
1
98
1CYV
1
98
P01040
A
1
1
98
1
MET
engineered mutation
LEU
65
1CYV
A
P01040
UNP
65
65
5
5
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
GLU
8
A
GLU
8
A
PRO
11
A
PRO
11
A
GLN
42
A
GLN
42
A
VAL
47
A
VAL
47
A
GLY
50
A
GLY
50
A
ALA
59
A
ALA
59
A
LYS
63
A
LYS
63
A
SER
72
A
SER
72
A
LEU
80
A
LEU
80
A
LEU
82
A
LEU
82
A
GLU
8
A
GLU
8
A
PRO
11
A
PRO
11
A
LEU
38
A
LEU
38
A
ALA
40
A
ALA
40
A
GLY
50
A
GLY
50
A
ALA
59
A
ALA
59
A
LYS
63
A
LYS
63
A
SER
72
A
SER
72
A
GLY
84
A
GLY
84
A
VAL
87
A
VAL
87
1
P 1